MICROANEURYSM FORMATION RATE AS A PREDICTIVE MARKER FOR PROGRESSION TO CLINICALLY SIGNIFICANT MACULAR EDEMA IN NONPROLIFERATIVE DIABETIC RETINOPATHY

被引:53
|
作者
Haritoglou, Christos [1 ]
Kernt, Marcus [1 ]
Neubauer, Aljoscha [1 ]
Gerss, Joachim [2 ]
Oliveira, Carlos Manta [3 ]
Kampik, Anselm [1 ]
Ulbig, Michael [1 ]
机构
[1] Univ Munich, Dept Ophthalmol, D-80336 Munich, Germany
[2] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany
[3] Crit Hlth SA, Coimbra, Portugal
关键词
diabetic macular edema; progression; microaneurysm turnover; TURNOVER;
D O I
10.1097/IAE.0b013e318295f6de
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the predictive value of microaneurysm (MA) formation rate concerning the development of clinically significant macular edema (CSME) in patients with mild-to-moderate nonproliferative diabetic retinopathy as evaluated by an automated analysis of central field fundus 30 degrees photographs. Methods: Two hundred and eighty-seven eyes were included in the study. Photographs obtained at Day 0, at 6, and 12 months were analyzed using the RetmarkerDR software (Critical Health SA) in a masked manner, and the MA formation rate was documented. A threshold of a calculated MA formation rate of 2 or more was chosen to consider a patient "positive." The ability to predict CSME development was then calculated for a period of up to 5 years. HbA1c values, blood pressure, or duration of diabetes were also evaluated. Results: The study population consisted of 89 male and 59 female patients with a mean age of 57.6 years, a mean HbA1c of 7.8, and a mean duration of diabetes of 12.3 years. Forty-seven of 287 eyes (16.4%) developed CSME during follow-up. An increased MA formation rate of > 2 MA was clearly associated with development of CSME. Using the automated analysis and a threshold of 2 or more new MA, the authors were able to identify 70.2% of the eyes that developed CSME during follow-up ("true positive") and using a threshold of up to 2 new MA, 71.7% of the patients that did not develop CSME ("true negative"). No significant differences concerning baseline and 1-year HbA1c levels within patient eyes that developed CSME compared with patient eyes below or over the calculated threshold of 2 MA (P = 0.554 and P = 0.890, respectively) were seen. The positive and negative predictive value was calculated to be 33% versus 92.5%, sensitivity was 70%, and specificity was 72%. Conclusion: Using the RetmarkerDR software, the authors were able to identify patients with higher risk to develop CSME during follow-up using a threshold of 2 or more MA formation rate. Together with the high negative predictive value, the automated analysis may help to determine the individual risk of a patient to develop sight-threatening complications related to diabetic retinopathy and schedule individual screening intervals.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [1] Microaneurysm Turnover and Phenotypes of Nonproliferative Diabetic Retinopathy Progression to Clinically Significant Macular Edema
    Cunha-Vaz, J.
    INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, : 51 - 54
  • [2] Microaneurysm Turnover Is a Biomarker for Diabetic Retinopathy Progression to Clinically Significant Macular Edema: Findings for Type 2 Diabetics with Nonproliferative Retinopathy
    Nunes, Sandrina
    Pires, Isabel
    Rosa, Andreia
    Duarte, Lilianne
    Bernardes, Rui
    Cunha-Vaz, Jose
    OPHTHALMOLOGICA, 2009, 223 (05) : 292 - 297
  • [3] Microaneurysm Turnover at the Macula Predicts Risk of Development of Clinically Significant Macular Edema in Persons With Mild Nonproliferative Diabetic Retinopathy
    Ribeiro, Maria Luisa
    Nunes, Sandrina G.
    Cunha-Vaz, Jose G.
    DIABETES CARE, 2013, 36 (05) : 1254 - 1259
  • [4] Three Different Phenotypes of Mild Nonproliferative Diabetic Retinopathy With Different Risks for Development of Clinically Significant Macular Edema
    Nunes, Sandrina
    Ribeiro, Luisa
    Lobo, Conceicao
    Cunha-Vaz, Jose
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (07) : 4595 - 4604
  • [5] MICROANEURYSM TURNOVER PREDICTS RISK OF DEVELOPMENT OF CLINICALLY SIGNIFICANT DIABETIC MACULAR EDEMA
    Ribeiro, L.
    Nunes, S.
    Cunha-Vaz, J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (03) : 448 - 448
  • [6] Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification:: Prospective study
    Romero-Aroca, Pedro
    Fernandez-Ballart, Juan
    Almena-Garcia, Matias
    Mendez-Marin, Isabel
    Salvat-Serra, Merce
    Buil-Calvo, Jose A.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2006, 32 (09): : 1438 - 1444
  • [7] Diabetic retinopathy with or without clinically significant macular edema: The influencing factors
    Suwal, Barsha
    Shrestha, Jeevan Kumar
    Joshi, Sagun Narayan
    Sharma, Ananda Kumar
    NEPALESE JOURNAL OF OPHTHALMOLOGY, 2015, 7 (02) : 142 - 147
  • [8] Foveal cone function in nonproliferative diabetic retinopathy and macular edema
    Weiner, A
    Christopoulos, VA
    Gussler, CH
    Adams, DH
    Kaufman, SR
    Kohn, HD
    Weidenthal, DT
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (07) : 1443 - 1449
  • [9] Predicting the development of clinically significant macular edema (CSME) in patients with mild nonproliferative diabetic retinopathy (NPDR) using machine learning (ML)
    Damopoulos, Dimitrios
    Mendes, Luis
    Santos, Torcato
    Neubert, Ales
    Armendariz, Beatriz Garcia
    Weikert, Robert
    Ferrara, Daniela
    Cunha-Vaz, Jose G.
    Benmansour, Fethallah
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [10] Retinal images benchmark for the detection of diabetic retinopathy and clinically significant macular edema (CSME)
    Noor-ul-huda, Muhammad
    Tehsin, Samabia
    Ahmed, Sairam
    Niazi, Fuad A. K.
    Murtaza, Zeerish
    BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK, 2019, 64 (03): : 297 - 307